Nearly 40% of U.S. adults have metabolic syndrome, a condition that can lead to liver damage and fibrosis.
A new study from Sanford Burnham Prebys highlights LARP6, an RNA-binding protein that helps drive fibrosis and may be a promising therapeutic target.
sbpdiscovery.org/press/living...
